Version 3.0 of this working paper presents the AI-Supported Work Authorization Cycle for deciding whether a defined pharmaceutical AI workflow may proceed, under what conditions, on what evidence, and what finding requires restriction or withdrawal. It adds a worked Stage 3 acceptance criterion, a filled fictional-manufacturer Gate Decision Record, a consolidated first-appearance source list, and a fictional worked example. Supporting templates are available at https://www.gxpframe.com/governing-ai/.
No takes yet. Share an insight, caveat, or question.
Brian Drapeau (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: